Skip to search formSkip to main contentSkip to account menu

bleomycin/dacarbazine/doxorubicin/vinblastine protocol

Known as: ABVD, ABVD Regimen, Adriamycin-Bleomycin-Vinblastine-Dacarbazine Regimen 
A chemotherapy regimen consisting of doxorubicin hydrochloride (Adriamycin), bleomycin, vinblastine and dacarbazine, used alone or in combination… 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (1)

ABVD protocol
Adult Hodgkin LymphomaBleomycinDacarbazineDoxorubicin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Copyright © 2017 Massachusetts Medical Society. BACKGROUND Brentuximab vedotin is an anti-CD30 antibody–drug conjugate that has… 
Highly Cited
2014
Highly Cited
2014
Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis.
Due to disease rarity, there is limited information regarding the optimal therapy and outcome for patients with advanced-stage… 
Highly Cited
2012
Highly Cited
2012
International Prognostic Score in advanced-stage Hodgkin's lymphoma: altered utility in the modern era.
PURPOSE The International Prognostic Score (IPS) is the most widely used risk stratification index for Hodgkin's lymphoma (HL… 
Review
2010
Review
2010
Early-stage Hodgkin's lymphoma.
This article summarizes the issues involved in the treatment of patients with early-stage Hodgkin's lymphoma. Long-term follow-up… 
Review
2005
Review
2005
State-of-the-art therapeutics: Hodgkin's lymphoma.
Presently Hodgkin's lymphoma can be cured in at least 80% of patients. The major challenge to the clinician in 2005 is how to… 
Highly Cited
1995
Highly Cited
1995
Incidence of second cancers in patients treated for Hodgkin's disease.
BACKGROUND Numerous studies of treatment for Hodgkin's disease have demonstrated large increases in the incidence of leukemia in… 
Highly Cited
1993
Highly Cited
1993
Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and…
PURPOSE To compare (1) clinical staging and irradiation alone versus staging laparotomy and treatment adaptation in patients with… 
Highly Cited
1984
Highly Cited
1984
The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984.
Highly Cited
1982
Highly Cited
1982
Alternating drug combinations in the treatment of advanced Hodgkin's disease.
Of 75 consecutive patients with Stage IV Hodgkin's disease, we assigned 38 to receive MOPP alone (mechlorethamine, vincristine… 
Review
1980
Review
1980
Second malignancies in Hodgkin's disease: a complication of certain forms of treatment.
A total of 764 patients with Hodgkin's disease treated with radiotherapy (RT) or chemotherapy or both were reviewed 3-186 months… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)